EUNETWORKS
7.12.2023 09:01:28 CET | Business Wire | Press release
euNetworks Group Limited (“euNetworks”), a Western European bandwidth infrastructure company, was recently featured in an interview series with leaders from across industries undertaken during the United Nations Climate Conference (COP28) in Dubai. The series of interviews captures lessons learned, sustainability success stories and key messages for the future from leaders across the energy, technology and telecom, manufacturing and finance industries. euNetworks has also released its latest Sustainability Report, detailing the company’s commitment to sustainability and substantial progress over the last year.
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20231207410743/en/
Paula Cogan, CEO of euNetworks (Photo: Business Wire)
euNetworks builds and invests in city and long haul fibre networks to connect key European data centres and data hubs. The company owns and operates deep fibre networks in 17 cities and also operates a highly differentiated long haul network that spans 66,000 kilometres across 17 countries today. As a specialist in the sector, euNetworks continues to grow and invest in partnership with its customers, investing in new technologies and deepening its unique fibre network in Europe. The company is undertaking this growth with a strong focus on sustainability and has been working hard through 2023 to deliver tangible progress on its long-term sustainability goals.
“Throughout euNetworks’ history, we have remained dedicated to our core values, and our commitment to sustainability has never been stronger,” said Paula Cogan, Chief Executive Officer of euNetworks. “We understand the impact our operations can have on the environment, and we are committed to reducing our carbon footprint and contributing to global efforts in combatting climate change and transitioning to a low-carbon economy.”
COP28 has a focus on four paradigm shifts – fast-tracking the energy transition and slashing emissions before 2030; transforming climate finance by delivering on old promises and setting the framework for a new deal on finance; putting nature, people, lives, and livelihoods at the heart of climate action; and mobilising for the most inclusive COP ever. euNetworks’ efforts align with those shifts.
“Our pledge to be net-zero carbon by 2040 is not just an aspiration but a driving force behind our actions,” said Cogan. “We have joined the Climate Pledge, demonstrating our unwavering commitment to combat climate change. Setting 1.5°C-aligned science-based targets across Scopes 1, 2, and 3 is a testament to euNetworks’ ambition to be leaders in environmental responsibility in the digital infrastructure ecosystem. We shifted to renewable energy sources across our business, and we’ve reached our target of 98.8% today. We obtained a Sustainability Linked Loan in 2021 that enabled us to embed our commitment to sustainability by including ESG-linked KPIs into our financial framework. We are dedicated to pioneering innovation in carbon measurement tools for service and project-based emissions, empowering our customers to measure and address Scope 3 emissions with precision, and helping suppliers to reduce their carbon footprint. Our award-winning carbon tools are actively used in our operations and by our customers today. We aim to deliver the lowest carbon footprint per bit of data transmitted, which we take seriously and drives our daily efforts.”
euNetworks’ sustainability strategy, outlined in the company’s latest Sustainability Report, encompasses long-term objectives, focusing on carbon neutrality, a diverse, equitable, and inclusive workforce, responsible supply chain management, customer-driven innovation, and biodiversity conservation:
- Net Zero: We have set our sights on achieving net-zero carbon emissions by 2040. This ambitious target involves increasing our use of renewable energy sources, implementing innovative technologies, and adopting efficient operational practices to minimise environmental impact.
- Diverse, Equitable, and Inclusive workforce: We champion an inclusive culture that values the richness of our employees' backgrounds and perspectives. We prioritise building a diverse, equitable and inclusive culture, and our goal is to achieve gender balance in our workforce, positioning us as a preferred employer within the telecoms industry.
- Responsible Supply Chain Management: We collaborate with our partners to establish responsible supply chain practices. This involves promoting transparency, ethical sourcing, and reducing our environmental footprint.
- Customer-Focused Innovation: We are committed to ongoing innovation, developing bandwidth infrastructure solutions prioritising energy efficiency, emissions reduction, and circular economy principles.
- Biodiversity Preservation: Our dedication extends to contributing to biodiversity conservation and ecosystem resilience. Our initiatives promote biodiversity awareness, protect natural habitats and support reforestation efforts.
“It’s clear that while euNetworks has made great progress towards its sustainability goals, we are still at the beginning of our journey,” said Cogan. “Collaboration among suppliers, customers, partners and the broader ecosystem will be essential to achieving substantial, long-term environmental change. In an industry fundamental to economies and society, euNetworks is committed to making significant sustainability strides of its own and supporting the bigger picture of businesses working together to solve the immense challenges of sustainability and climate change.”
To read euNetworks’ full Sustainability Report, go to https://eun.io/sustainability
About euNetworks
euNetworks is a critical bandwidth infrastructure company, owning and operating 17 fibre-based metropolitan networks connected with a high capacity intercity backbone covering 53 cities in 17 countries across Europe. The company leads the market in data centre connectivity, directly connecting over 518 today. euNetworks is also a leading cloud connectivity provider and offers a targeted portfolio of metropolitan and long haul services including Dark Fibre, Wavelengths, and Ethernet. Wholesale, finance, content, media, mobile, data centre and enterprise customers benefit from euNetworks’ unique inventory of fibre and duct based assets that are tailored to fulfil their high bandwidth needs. For further information visit eunetworks.com.
To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.
View source version on businesswire.com: https://www.businesswire.com/news/home/20231207410743/en/
About Business Wire
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Galderma Receives U.S. FDA Approval for Differin® Epiduo® Acne Gel Prescription-to-OTC Switch22.5.2026 18:25:00 CEST | Press release
A unique Prescription-to-OTC switch in acne care, this approval expands access to a dermatologist-trusted, prescription-strength treatment for millions of acne sufferers ages 12 years and older Backed by more than 15 years of real-world dermatologist use and a robust clinical research program, this milestone demonstrates the depth of science behind the Differin® and Epiduo® heritage Adapalene plus benzoyl peroxide (0.1/2.5%) was the first FDA-approved, stable, fixed- dose prescription acne treatment to combine of benzoyl peroxide with a retinoid, and is now available over-the-counter The formulation is engineered to target multiple causes of acne more effectively than either of its individual active ingredients alone Galderma (SIX: GALD), the pure-play dermatology category leader, today announced that the United States (U.S.) Food and Drug Administration (FDA) has approved Differin® Epiduo® Acne Gel (Adapalene 0.1% and Benzoyl Peroxide 2.5% Acne Treatment) for over-the-counter (OTC) us
Avanzanite Bioscience’s Partner Agios Announces PYRUKYND® (mitapivat) Approval in the European Union for Adults with Thalassaemia22.5.2026 16:18:00 CEST | Press release
Avanzanite will commercialise and distribute PYRUKYND in Europe under its exclusive agreement with Agios Avanzanite is committed to collaborating with local authorities in the EU to enable access to PYRUKYND for adult patients with thalassaemia Avanzanite Bioscience B.V., a rapidly growing commercial-stage European specialty pharmaceutical company focused on rare diseases, today reported that its partner, Agios Pharmaceuticals, Inc. (Nasdaq: AGIO), a commercial-stage biopharmaceutical company headquartered in Cambridge, Massachusetts focused on delivering innovative medicines for patients with rare diseases, announced that the European Commission has granted marketing authorisation for PYRUKYND® (mitapivat), an oral pyruvate kinase (PK) activator, in adults for the treatment of anaemia associated with transfusion-dependent and non-transfusion-dependent alpha- or beta-thalassaemia, with an orphan medicinal product designation. This press release features multimedia. View the full releas
ICE Brent and ICE WTI Perpetual Futures to Launch on OKX22.5.2026 14:30:00 CEST | Press release
OKX, a blockchain technology and trading company serving more than 120 million customers globally,and Intercontinental Exchange (NYSE: ICE), one of the world's leading providers of financial market technology and data powering global capital markets including the New York Stock Exchange, today announced plans for OKX to launch perpetual futures based on ICE's Brent Crude and WTI Crude energy benchmarks. The products are expected to be available to trade on OKX’s platform in jurisdictions where OKX is licensed to offer perpetual futures products. The new OKX contracts represent a major step forward in expanding regulated access to global commodity markets through digital asset infrastructure. This first product collaboration between OKX and ICE comes after the companies established a strategic relationship in March 2026. ICE operates some of the world’s leading exchanges, clearing houses and market data services across energy, commodities, fixed income and equities markets. ICE’s future
Enhertu® Recommended for Approval in the EU by CHMP for Patients with Previously Treated HER2 Positive Metastatic Solid Tumors22.5.2026 14:00:00 CEST | Press release
Enhertu® (trastuzumab deruxtecan) has been recommended for approval in the European Union (EU) as a monotherapy for the treatment of adult patients with unresectable or metastatic HER2 positive (immunohistochemistry [IHC] 3+) solid tumors who have received prior treatment and who have no satisfactory treatment options. Enhertu is a specifically engineered HER2 directed DXd antibody drug conjugate (ADC) discovered by Daiichi Sankyo (TSE: 4568) and being jointly developed and commercialized by Daiichi Sankyo and AstraZeneca (LSE/STO/NYSE: AZN). The Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) based its positive opinion on results from patients with HER2 positive (IHC 3+) tumors in three phase 2 trials including DESTINY-PanTumor02,DESTINY-Lung01 andDESTINY-CRC02 where Enhertu demonstrated clinically meaningful responses across a broad range of tumors. The recommendation will now be reviewed by the European Commission, which has the authority
Future Health Challenge Awards USD 300,000 to Early Detection and Population Health Sensing Tools on Sidelines of World Health Assembly22.5.2026 13:45:00 CEST | Press release
Global teams recognised in the Future Health Challenge for solutions designed to detect health risks earlier and support faster health system decisions Future Health – A Global Initiative by Abu Dhabi and MIT Solve announce the winners of the inaugural Future Health ChallengeWinning solution equips frontline health workers in low-resource settings with mobile clinical decision-support tools, enabling earlier detection and more effective care deliveryTeams competed for a USD 200,000 grand prize and two USD 50,000 runner-up awards on the sidelines of the 79th World Health Assembly in GenevaWinners recognised for solutions advancing anticipatory, data-driven health systems Three global teams developing early detection and real-time population health monitoring solutions have secured a total of USD 300,000 on the sidelines of the 79th World Health Assembly. The winning solutions address critical challenges in early detection, continuous population insight and more timely decision making, s
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom
